Allurion Technologies Inc. (ALUR)
OTCMKTS · Delayed Price · Currency is USD
1.950
-0.340 (-14.85%)
At close: Aug 20, 2026
Allurion Technologies Revenue
Allurion Technologies had revenue of $2.95M in the quarter ending March 31, 2026, a decrease of -47.19%. This brings the company's revenue in the last twelve months to $12.60M, down -55.49% year-over-year. In the year 2025, Allurion Technologies had annual revenue of $15.23M, down -52.57%.
Revenue (ttm)
12.60M
Revenue Growth
-55.49%
P/S Ratio
0.15
Revenue / Employee
314.93K
Employees
41
Market Cap
1.95M
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2025 | 15.23M | -16.88M | -52.57% |
| Dec 31, 2024 | 32.11M | -21.36M | -39.94% |
| Dec 31, 2023 | 53.47M | -10.74M | -16.73% |
| Dec 31, 2022 | 64.21M | 25.97M | 67.91% |
| Dec 31, 2021 | 38.24M | - | - |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Related Stocks
| Company Name | Revenue |
|---|---|
| Sonendo | 31.70M |
| Fuse Medical | 18.40M |
| Biotricity | 16.40M |
| Escalon Medical | 11.45M |
| ADM Tronics Unlimited | 3.24M |
| Vycor Medical | 1.81M |
| CS Diagnostics | 204.00K |
| REMSleep Holdings | 11.90K |